Unknown

Dataset Information

0

Activatable Singlet Oxygen Generation from Lipid Hydroperoxide Nanoparticles for Cancer Therapy.


ABSTRACT: Reactive oxygen species (ROS)-induced apoptosis is a widely practiced strategy for cancer therapy. Although photodynamic therapy (PDT) takes advantage of the spatial-temporal control of ROS generation, the meticulous participation of light, photosensitizer, and oxygen greatly hinders the broad application of PDT as a first-line cancer treatment option. An activatable system has been developed that enables tumor-specific singlet oxygen (1 O2 ) generation for cancer therapy, based on a Fenton-like reaction between linoleic acid hydroperoxide (LAHP) tethered on iron oxide nanoparticles (IO NPs) and the released iron(II) ions from IO NPs under acidic-pH condition. The IO-LAHP NPs are able to induce efficient apoptotic cancer cell death both in?vitro and in?vivo through tumor-specific 1 O2 generation and subsequent ROS mediated mechanism. This study demonstrates the effectiveness of modulating biochemical reactions as a ROS source to exert cancer death.

SUBMITTER: Zhou Z 

PROVIDER: S-EPMC5634745 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Activatable Singlet Oxygen Generation from Lipid Hydroperoxide Nanoparticles for Cancer Therapy.

Zhou Zijian Z   Song Jibin J   Tian Rui R   Yang Zhen Z   Yu Guocan G   Lin Lisen L   Zhang Guofeng G   Fan Wenpei W   Zhang Fuwu F   Niu Gang G   Nie Liming L   Chen Xiaoyuan X   Chen Xiaoyuan X  

Angewandte Chemie (International ed. in English) 20170504 23


Reactive oxygen species (ROS)-induced apoptosis is a widely practiced strategy for cancer therapy. Although photodynamic therapy (PDT) takes advantage of the spatial-temporal control of ROS generation, the meticulous participation of light, photosensitizer, and oxygen greatly hinders the broad application of PDT as a first-line cancer treatment option. An activatable system has been developed that enables tumor-specific singlet oxygen (<sup>1</sup> O<sub>2</sub> ) generation for cancer therapy,  ...[more]

Similar Datasets

| S-EPMC4878812 | biostudies-literature
| S-EPMC7069247 | biostudies-literature
| S-EPMC6385666 | biostudies-literature
| S-EPMC5896663 | biostudies-literature
| S-EPMC4730142 | biostudies-literature
| S-EPMC5521840 | biostudies-literature
| S-EPMC4515827 | biostudies-other
| S-EPMC4143951 | biostudies-literature
| S-EPMC6203243 | biostudies-literature
| S-EPMC6524665 | biostudies-literature